154 related articles for article (PubMed ID: 30342872)
1. Risk score system for the prediction of hepatocellular carcinoma in patients with type 2 diabetes: Taiwan Diabetes Study.
Li TC; Li CI; Liu CS; Lin WY; Lin CH; Yang SY; Lin CC
Semin Oncol; 2018 Oct; 45(5-6):264-274. PubMed ID: 30342872
[TBL] [Abstract][Full Text] [Related]
2. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes.
Si WK; Chung JW; Cho J; Baeg JY; Jang ES; Yoon H; Kim J; Shin CM; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH; Lim S; Kim JW
PLoS One; 2016; 11(6):e0158066. PubMed ID: 27359325
[TBL] [Abstract][Full Text] [Related]
4. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study.
Li CI; Chen HJ; Lai HC; Liu CS; Lin WY; Li TC; Lin CC
Int J Cancer; 2015 Jun; 136(11):2668-79. PubMed ID: 25387451
[TBL] [Abstract][Full Text] [Related]
6. Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.
Sohn W; Cho JY; Kim JH; Lee JI; Kim HJ; Woo MA; Jung SH; Paik YH
Clin Mol Hepatol; 2017 Jun; 23(2):170-178. PubMed ID: 28506056
[TBL] [Abstract][Full Text] [Related]
7. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.
Yang HI; Yuen MF; Chan HL; Han KH; Chen PJ; Kim DY; Ahn SH; Chen CJ; Wong VW; Seto WK;
Lancet Oncol; 2011 Jun; 12(6):568-74. PubMed ID: 21497551
[TBL] [Abstract][Full Text] [Related]
8. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.
Papatheodoridis G; Dalekos G; Sypsa V; Yurdaydin C; Buti M; Goulis J; Calleja JL; Chi H; Manolakopoulos S; Mangia G; Gatselis N; Keskin O; Savvidou S; de la Revilla J; Hansen BE; Vlachogiannakos I; Galanis K; Idilman R; Colombo M; Esteban R; Janssen HL; Lampertico P
J Hepatol; 2016 Apr; 64(4):800-6. PubMed ID: 26678008
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases.
Wen CP; Lin J; Yang YC; Tsai MK; Tsao CK; Etzel C; Huang M; Hsu CY; Ye Y; Mishra L; Hawk E; Wu X
J Natl Cancer Inst; 2012 Oct; 104(20):1599-611. PubMed ID: 23073549
[TBL] [Abstract][Full Text] [Related]
10. Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: the Japan Public Health Center-based Prospective Study Cohort II.
Michikawa T; Inoue M; Sawada N; Iwasaki M; Tanaka Y; Shimazu T; Sasazuki S; Yamaji T; Mizokami M; Tsugane S;
Prev Med; 2012 Aug; 55(2):137-43. PubMed ID: 22676909
[TBL] [Abstract][Full Text] [Related]
11. Risk score prediction model for dementia in patients with type 2 diabetes.
Li CI; Li TC; Liu CS; Liao LN; Lin WY; Lin CH; Yang SY; Chiang JH; Lin CC
Eur J Neurol; 2018 Jul; 25(7):976-983. PubMed ID: 29603513
[TBL] [Abstract][Full Text] [Related]
12. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.
Flemming JA; Yang JD; Vittinghoff E; Kim WR; Terrault NA
Cancer; 2014 Nov; 120(22):3485-93. PubMed ID: 25042049
[TBL] [Abstract][Full Text] [Related]
14. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
[TBL] [Abstract][Full Text] [Related]
16. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
17. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.
Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Tanaka J
J Gastroenterol Hepatol; 2017 Feb; 32(2):451-458. PubMed ID: 27288655
[TBL] [Abstract][Full Text] [Related]
18. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
19. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
[TBL] [Abstract][Full Text] [Related]
20. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ
J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
